Schedule 13D ownership disclosure
Edgewise Therapeutics Inc
Security class unavailable · CUSIP: 28036F105
Event date: 2022-02-25
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 0
- Percent of class
- 0.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-23-009149
- Form type
- SC 13D
- Filer
- Edgewise Therapeutics, Inc.
- CIK
- CIK 1710072
- Filed
- Feb 01, 2023
- Reporting period
- Feb 25, 2022
- Description
- Schedule 13D beneficial ownership